Atlas Trials

Comprehensive Biomarker Profiling of the IFN-α Pathway in Amyotrophic Lateral Sclerosis Patient Biofluids

Clinical trial NCT07260981 · COMPLETED

Trial details

NCT number
NCT07260981
Sponsor
Ulysses Neuroscience LTD
Status
COMPLETED
Study type
OBSERVATIONAL
ALS - Amyotrophic Lateral Sclerosis
Start date
2023-03-01
Primary completion
2025-01-18
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.